Newly Identified BRAF Mutation in Rheumatoid Arthritis

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Rheumatoid arthritis (RA) involves autoantibodies targeting BRAF kinase.
• BRAF is a key kinase in the MAPK signaling pathway.

Purpose of the Study:

• Identify BRAF mutations in peripheral blood lymphocytes (PBLs) of RA patients.
• Investigate the functional impact of identified BRAF mutations on kinase activity.

Main Methods:

• Cloning and sequencing of the BRAF gene from RA patient PBLs.
• Droplet digital PCR for mutation frequency analysis.
• In vitro kinase assay to assess MEK-1 phosphorylation.

Main Results:

• A novel BRAF mutation, p.Val600Ala, was identified in RA patient PBLs and T lymphocytes.
• The p.Val600Ala mutation demonstrated increased BRAF kinase activity in vitro.
• No correlation was found between p.Val600Ala and anti-BRAF autoantibodies.

Conclusions:

• The p.Val600Ala mutation is prevalent in RA patients and activates BRAF kinase.
• This activation may lead to MAPK pathway signaling and T lymphocyte activation in RA.